Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting in increased usage worldwide. Likewise, insulin pumps are becoming smarter and easier to use. More recently, sensor-augmented insulin pump therapy has been improved, providing significant benefits for patients by optimizing blood glucose control and preventing hypoglycemia. Further progress has been made with the introduction of advanced closed-loop control (CLC) systems, which combine both technologies with an algorithm that minimizes hypo- and hyperglycemia through self-correcting boluses.
Various clinical trials conducted to test these new technologies have reported improvements in HbA1c, CGM-based glycemic parameters, and patient satisfaction. At the same time, new devices, including interoperable systems, are continuously being introduced to the market, generating high expectations among patients. However, few studies report long-term clinical data in real-life settings, guidance on how to initiate patients on these technologies, strategies to overcome barriers in their daily use, or information on reimbursement by public health systems.
This Research Topic welcomes manuscripts in the form of reviews, research papers, case series, or case reports. Articles should focus on real-world data, clinical practice, and diabetes technology in children, adolescents, and young adults, providing practical approaches to their use. Papers on blood glucose control, quality of life, or related topics will be considered for publication.
Special attention will be given to the following topics:
• Insulin pumps
• Continuous glucose monitoring
• Sensor-augmented pumps
• Closed-loop control systems
• Automated decision support systems
• Telemedicine
• Technology education
• Technology reimbursement
Authors are welcome to propose any other relevant topics not included in this list. Proposals should be submitted via email to the editorial staff for evaluation to determine whether they fall within the scope of this Research Topic.
Topic Editor Roque Cardona-Hernandez has received speaker honoraria from Abbott, Medtronic, Novalab, Novo Nordisk, and Sanofi, and has served on advisory boards for Sanofi and Dexcom.
Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting in increased usage worldwide. Likewise, insulin pumps are becoming smarter and easier to use. More recently, sensor-augmented insulin pump therapy has been improved, providing significant benefits for patients by optimizing blood glucose control and preventing hypoglycemia. Further progress has been made with the introduction of advanced closed-loop control (CLC) systems, which combine both technologies with an algorithm that minimizes hypo- and hyperglycemia through self-correcting boluses.
Various clinical trials conducted to test these new technologies have reported improvements in HbA1c, CGM-based glycemic parameters, and patient satisfaction. At the same time, new devices, including interoperable systems, are continuously being introduced to the market, generating high expectations among patients. However, few studies report long-term clinical data in real-life settings, guidance on how to initiate patients on these technologies, strategies to overcome barriers in their daily use, or information on reimbursement by public health systems.
This Research Topic welcomes manuscripts in the form of reviews, research papers, case series, or case reports. Articles should focus on real-world data, clinical practice, and diabetes technology in children, adolescents, and young adults, providing practical approaches to their use. Papers on blood glucose control, quality of life, or related topics will be considered for publication.
Special attention will be given to the following topics:
• Insulin pumps
• Continuous glucose monitoring
• Sensor-augmented pumps
• Closed-loop control systems
• Automated decision support systems
• Telemedicine
• Technology education
• Technology reimbursement
Authors are welcome to propose any other relevant topics not included in this list. Proposals should be submitted via email to the editorial staff for evaluation to determine whether they fall within the scope of this Research Topic.
Topic Editor Roque Cardona-Hernandez has received speaker honoraria from Abbott, Medtronic, Novalab, Novo Nordisk, and Sanofi, and has served on advisory boards for Sanofi and Dexcom.